Replies to post #546826 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

I welcome all fact-checking using valid full-context sources. Prove me wrong!

I named ECA approvals from memory, but then quoted excerpts from the article that you cited which named those very same drugs.

The article named several of those drugs that I had mentioned. If I recall, the ECA data were deemed supportive, and FDA approval was indeed still granted:

“Blinatumomab was granted accelerated approval for the treatment of adults and children with B-cell precursor (BCP) acute lymphoblastic leukemia.”

“In April 2020, the FDA approved selumetinib for pediatric patients, 2 years of age and older, with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas”

[MasterBlastr]

He is right, completely fact-checked, air tight, lead pipe cinch.